Wade K. Dawe

All filings by Wade K. Dawe on record concern Immunovaccine Inc. In total, 12 filings cover trades dated from 25 September 2014 to 24 April 2017.

The open-market record is one-sided, with 8 purchases worth €86k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 option exercise. Since January 2017: 1 purchase and no sales on the market.

A typical purchase (the median) is worth €9,883.

The latest filing, published on 29 April 2017, reports an option exercise in Immunovaccine Inc. The last insider purchase was made public on 7 March 2017, 3,518 days ago. Filings reach the SEDI feed a median of 3 days after the trade. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.